What does LEJEUNE-GAIE MEDICAL MGMU do?

LEJEUNE-GAIE MEDICAL MGMU is a general practice in La Bruyère. Private Limited, started on 31 March 2014, 2 establishments.

What is the address of LEJEUNE-GAIE MEDICAL MGMU?

The registered office of LEJEUNE-GAIE MEDICAL MGMU is located at Rue de la Ridale, Meux 43, 5081 La Bruyère.

Is LEJEUNE-GAIE MEDICAL MGMU still active?

Yes. According to the CBE (18 September 2026) LEJEUNE-GAIE MEDICAL MGMU is active, legal situation “Normale toestand”, started on 31 March 2014.

Is LEJEUNE-GAIE MEDICAL MGMU registered on Peppol?

Yes, LEJEUNE-GAIE MEDICAL MGMU is registered on the Peppol network with ID 0208:0549856376.

What is the enterprise number of LEJEUNE-GAIE MEDICAL MGMU?

The enterprise number of LEJEUNE-GAIE MEDICAL MGMU is BE0549856376.

When was LEJEUNE-GAIE MEDICAL MGMU founded?

LEJEUNE-GAIE MEDICAL MGMU was founded on 31 March 2014.

Who are the directors of LEJEUNE-GAIE MEDICAL MGMU?

According to the 2025 annual accounts, the directors of LEJEUNE-GAIE MEDICAL MGMU are: François LEJEUNE, Caroline GAIE.

Is LEJEUNE-GAIE MEDICAL MGMU a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 March 2014; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did LEJEUNE-GAIE MEDICAL MGMU make in 2025?

LEJEUNE-GAIE MEDICAL MGMU posted a profit after taxes of € 147,441 in financial year 2025.

What is the revenue of LEJEUNE-GAIE MEDICAL MGMU?

As a small company, LEJEUNE-GAIE MEDICAL MGMU is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 197,902.

LEJEUNE-GAIE MEDICAL MGMU (Private Limited) - La Bruyère

Dossier LEJEUNE-GAIE MEDICAL MGMU, printed on 18 September 2026 from databakkes.be/en/0549856376/lejeune-gaie-medical-mgmu. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LEJEUNE-GAIE MEDICAL MGMU from La Bruyère, company number BE0549856376, closed financial year 2025 with a result of € 147,441 after tax. For that financial year LEJEUNE-GAIE MEDICAL MGMU recorded a gross margin of € 197,902 and equity of € 73,330. Compared with financial year 2024, the result moved from € 126,388 to € 147,441. Profitable, and profit is growing. The buffer shrank hard: equity is 60 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Shrank hard

€ 73,330

▼ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 147,441

▲ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,687

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 258,761 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,228

▼ 65% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2,308

▲ 24% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,319

▲ 213% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,701

▲ 78% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 140,251 Gross margin 2022: € 140,251 First fiscal year in the series	€ 153,361 Gross margin 2023: € 153,361 ▲ 9% vs 2022 (€ 140,251) Favourable step	€ 174,062 Gross margin 2024: € 174,062 ▲ 13% vs 2023 (€ 153,361) Favourable step	€ 197,902 Gross margin 2025: € 197,902 ▲ 14% vs 2024 (€ 174,062) Favourable step	▲ 14%
Profit after taxes	€ 92,793 Profit after taxes 2022: € 92,793 First fiscal year in the series	€ 108,565 Profit after taxes 2023: € 108,565 ▲ 17% vs 2022 (€ 92,793) Favourable step	€ 126,388 Profit after taxes 2024: € 126,388 ▲ 16% vs 2023 (€ 108,565) Favourable step	€ 147,441 Profit after taxes 2025: € 147,441 ▲ 17% vs 2024 (€ 126,388) Favourable step	▲ 17%
Equity	€ 273,490 Equity 2022: € 273,490 First fiscal year in the series	€ 75,190 Equity 2023: € 75,190 ▼ 73% vs 2022 (€ 273,490) Unfavourable step	€ 184,650 Equity 2024: € 184,650 ▲ 146% vs 2023 (€ 75,190) Favourable step	€ 73,330 Equity 2025: € 73,330 ▼ 60% vs 2024 (€ 184,650) Unfavourable step	▼ 60%
Total debts	€ 50,312 Total debts 2022: € 50,312 First fiscal year in the series	€ 166,686 Total debts 2023: € 166,686 ▲ 231% vs 2022 (€ 50,312) Unfavourable step	€ 28,097 Total debts 2024: € 28,097 ▼ 83% vs 2023 (€ 166,686) Favourable step	€ 170,081 Total debts 2025: € 170,081 ▲ € 141,984 vs 2024 (€ 28,097) Unfavourable step	▲ € 141,984
Cash	€ 236,900 Cash 2022: € 236,900 First fiscal year in the series	€ 148,849 Cash 2023: € 148,849 ▼ 37% vs 2022 (€ 236,900) Unfavourable step	€ 131,532 Cash 2024: € 131,532 ▼ 12% vs 2023 (€ 148,849) Unfavourable step	€ 142,687 Cash 2025: € 142,687 ▲ 8% vs 2024 (€ 131,532) Favourable step	▲ 8%
Retained profit	€ 254,890 Retained profit 2022: € 254,890 First fiscal year in the series	€ 56,590 Retained profit 2023: € 56,590 ▼ 78% vs 2022 (€ 254,890) Unfavourable step	€ 166,050 Retained profit 2024: € 166,050 ▲ 193% vs 2023 (€ 56,590) Favourable step	€ 54,730 Retained profit 2025: € 54,730 ▼ 67% vs 2024 (€ 166,050) Unfavourable step	▼ 67%
Dividend	€ 23,530 Dividend 2022: € 23,530 First fiscal year in the series	€ 306,865 Dividend 2023: € 306,865 ▲ € 283,335 vs 2022 (€ 23,530) Unchanged	€ 16,928 Dividend 2024: € 16,928 ▼ 94% vs 2023 (€ 306,865) Unchanged	€ 258,761 Dividend 2025: € 258,761 ▲ € 241,833 vs 2024 (€ 16,928) Unchanged	▲ € 241,833
Bank debt	€ 19,442 Bank debt 2022: € 19,442 First fiscal year in the series	€ 5,461 Bank debt 2023: € 5,461 ▼ 72% vs 2022 (€ 19,442) Favourable step	€ 1,861 Bank debt 2024: € 1,861 ▼ 66% vs 2023 (€ 5,461) Favourable step	€ 2,308 Bank debt 2025: € 2,308 ▲ 24% vs 2024 (€ 1,861) Unfavourable step	▲ 24%
Balance sheet total	€ 323,801 Balance sheet total 2022: € 323,801 First fiscal year in the series	€ 241,876 Balance sheet total 2023: € 241,876 ▼ 25% vs 2022 (€ 323,801) Unchanged	€ 212,747 Balance sheet total 2024: € 212,747 ▼ 12% vs 2023 (€ 241,876) Unchanged	€ 243,411 Balance sheet total 2025: € 243,411 ▲ 14% vs 2024 (€ 212,747) Unchanged	▲ 14%

Key figures of LEJEUNE-GAIE MEDICAL MGMU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LEJEUNE-GAIE MEDICAL MGMU?

What happened at LEJEUNE-GAIE MEDICAL MGMU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 147,441 (▲ 17% vs 2024). Source: NBB ↗
2026 François LEJEUNE stepped down as director. NBB
2026 Caroline GAIE stepped down as director. NBB
2020 François LEJEUNE became a director. NBB
2020 Caroline GAIE became a director. NBB
Apr 1, 2014 New establishment in La Bruyère. KBO
Apr 1, 2014 New establishment in Charleroi. KBO
Mar 31, 2014 Start of the company according to the CBE. KBO

In short

From € 92,793 profit in 2022 to € 147,441 profit in 2025.

Paid € 153,182 in corporate taxes since 2022.

Best year ever: 2025, with € 147,441 profit.

Paid out € 606,083 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at LEJEUNE-GAIE MEDICAL MGMU? We notify you, reason included.

Follow LEJEUNE-GAIE MEDICAL MGMU

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2025 annual accounts

François LEJEUNE

Director

since 2020 · until 2026

Caroline GAIE

Director

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Ridale, Meux 43

5081 La Bruyère

2.229.997.930

Rue de Dhuy, Warisoulx 9

5080 La Bruyère

Active since 1 April 2014

2.230.000.108

Chaussée de Nivelles 212

6041 Charleroi

Active since 1 April 2014

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0549.856.376
VAT number: BE 0549.856.376
Registered office: Rue de la Ridale, Meux 43, 5081 La Bruyère
Names & denominations: LEJEUNE-GAIE MEDICAL MGMU
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 March 2014
Peppol: Active · Active since 23 Feb 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

LEJEUNE-GAIE MEDICAL MGMU